[Sending recorded video] Cutting-edge pDNA and AAV therapeutics: Comprehensive upstream process technology covering everything from process development to actual production.

ザルトリウス・ステディム・ジャパン
Participation in this webinar has ended. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date. The development of therapeutics using viral vectors is showing strong activity, with over 30% market growth expected in the next decade. The targets for treatment are diverse, but identifying critical process parameters through process development has become an urgent issue. As the first of two webinars, we will introduce the Ambr series, a representative of process development systems in upstream processes, as well as single-use bag bioreactors up to 2000L for large-scale manufacturing, including examples of associated PAT products. *We sincerely apologize, but participation from email addresses other than those of your company or organization is not permitted. Thank you for your understanding.

-
Date and time Thursday, Aug 25, 2022
03:00 PM ~
- Entry fee Free
Related catalog


